See What HealthDay Can Do For You
Contact Us

Risk of GI Bleeding Varies by NSAID Type, Dosage

Slow-release formulations and COX-1 plus COX-2 inhibition linked to increased risk of bleeding

WEDNESDAY, June 2 (HealthDay News) -- The risk of gastrointestinal (GI) complications due to nonsteroidal anti-inflammatory drug (NSAID) use varies by the specific drug used and by dosage, and those with a slow-release formulation or long half-life are associated with a greater risk, according to research published in the June issue of Arthritis & Rheumatism.

Elvira L. Massó González, of the Spanish Centre for Pharmacoepidemiological Research in Madrid, Spain, and colleagues conducted a systematic review of observational studies from 2000 to 2008 on NSAIDs and upper GI bleeding or perforation.

The relative risk of upper GI bleeding/perforation was 4.50 for traditional NSAIDs and 1.88 for coxibs. Relative risks varied widely for specific drugs: ibuprofen, 2.69; rofecoxib, 2.12; aceclofenac, 1.44; celecoxib, 1.42; ketorolac, 14.54; piroxicam, 9.94; naproxen, 5.63; ketoprofen, 5.57; indomethacin, 5.40; meloxicam, 4.15; and diclofenac, 3.98. NSAIDs with a longer plasma half-life or extended-release formulations and those that inhibited both COX-1 and COX-2 were associated with a higher risk of upper GI bleeding/perforation.

"We showed that persistent exposure to the drug is an important independent determinant; in fact, drugs with a long half-life or slow-release formulation were associated overall with a greater risk than NSAIDs with a short half-life," the authors write. "We observed the lowest GI toxicity with coxibs, i.e., celecoxib and rofecoxib, which supports the notion that sparing of COX-1 in the GI tract and possibly in platelets translates clinically to a lower risk of upper GI bleeding/perforation."

One of the authors disclosed financial relationships with the pharmaceutical industry.

Full Text (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.